Analytical Data
-
基因名
gp130/IL6ST
- Application
-
别名
CDw130; CD130; IL6ST; GP130-RAPS; IR6RB; IL6R-Beta; IR6RB; IR6-RB; Interleukin 6 Signal Transducer; Oncostatin M Receptor; Interleukin-6 Receptor Subunit Beta
-
种属
Human
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by reducing SDS-PAGE.
-
蛋白编号
P40189
-
表达区间
Ser606~Gln756
-
分子量
21kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
gp130, also known as IL6ST (Interleukin-6 signal transducer), is a crucial co-receptor for various cytokines, including interleukin-6 (IL-6), and plays a significant role in the immune response, inflammation, and hematopoiesis. The gp130 signaling pathway is pivotal in mediating cellular responses to IL-6 family cytokines, and dysregulation of this pathway has been implicated in a range of diseases, including autoimmune disorders, cancers, and chronic inflammatory conditions. The study of recombinant gp130/IL6ST proteins is essential for elucidating the mechanisms underlying these pathologies and for the development of potential therapeutic strategies. By generating recombinant forms of gp130, researchers can investigate its structural and functional properties, assess its interactions with other signaling molecules, and evaluate the impact of specific mutations or modifications on its activity. Moreover, gp130's role in promoting cell proliferation and survival makes it an attractive target for drug development. Understanding gp130’s signaling dynamics and its influence on cellular pathways could pave the way for innovations in treating diseases characterized by abnormal cytokine signaling. Overall, the exploration of gp130/IL6ST recombinant proteins is vital for advancing knowledge in immunology and developing targeted therapies to combat cytokine-related diseases.
